Vivet Raises €37.5M to Develop Gene Therapies for Rare Liver Diseases – Genetic Engineering & Biotechnology News
FierceBiotech |
Vivet Raises €37.5M to Develop Gene Therapies for Rare Liver Diseases
Genetic Engineering & Biotechnology News French startup Vivet Therapeutics raised €37.5 million (about $41 million) in a Series A round of financing to support the development of gene therapies for rare inherited metabolic diseases. The firm was set up in 2016 to develop treatments based on … Swiss majors Roche and Novartis back gene therapy upstart Novartis, Roche back French gene therapy start-up Vivet French Gene Therapy Biotech Raises a Huge €37.5M in Series A |
